
GC74774
Farglitazar
Also known as (2S)-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoic acid
Farglitazar is a PPARγ agonist that has significant therapeutic benefits such as glycemic control in type 2 diabetic patients
ChemicalCAS196808-45-4MW546.61FormulaC34H30N2O5
- CAS number
- 196808-45-4
- Molecular weight
- 546.61
- Formula
- C34H30N2O5
- Solubility
- DMSO: 100 mg/mL (182·95 mM; Need ultrasonic)
- InChIKey
- ZZCHHVUQYRMYLW-HKBQPEDESA-N
- Catalogue number
- GC74774
- Brand
- GLPBIO
Computed properties PubChem CID 170364 · XLogP 7.8 · TPSA 102 Ų · H-bond donors 2
- XLogP
- 7.8
- TPSA
- 102 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Rotatable bonds
- 12
- Heavy atoms
- 41
SMILES CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)C[C@@H](C(=O)O)NC4=CC=CC=C4C(=O)C5=CC=CC=C5
Computed descriptors from PubChem (CID 170364), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il